• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制剂方法对载布洛芬无定形固体分散体的机械性能、溶出行为及压片特性的影响

Impact of Methods of Preparation on Mechanical Properties, Dissolution Behavior, and Tableting Characteristics of Ibuprofen-Loaded Amorphous Solid Dispersions.

作者信息

Uddin Ajam, Halder Shimul, Deb Nandita, Das Harinarayan, Shuma Madhabi Lata, Hasan Ikramul, Shill Manik Chandra, Haider Syed Shabbir

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.

Department of Physics, Faculty of Science, University of Dhaka, Dhaka 1000, Bangladesh.

出版信息

Adv Pharmacol Pharm Sci. 2024 May 28;2024:2303942. doi: 10.1155/2024/2303942. eCollection 2024.

DOI:10.1155/2024/2303942
PMID:38835733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11150040/
Abstract

This study aims to improve the biopharmaceutical, mechanical, and tableting properties of a poorly soluble drug, ibuprofen (IBP), by preparing amorphous solid dispersion (ASD) followed by a sustained-release tablet formulation. A suitable polymer to develop an ASD system was chosen by utilizing the apparent solubility of IBP in various polymer solutions. ASDs containing various ratios of IBP and selected polymer were prepared by the melt fusion (MF) method. ASD containing optimized drug-polymer ratio prepared by freeze-drying (FD) method was characterized and compared physicochemically. The solubility of IBP in water increased 28-fold and 35-fold when formulated as ASD by MF and FD, respectively. Precise formulations showed amorphization of IBP and increased surface area, improving solubility. The dissolution pattern of optimized ASD-IBP in pH 6.8 phosphate buffer after 60 min in MF and FD was enhanced 3-fold. In addition, direct compression tablets comprising optimized ASD granules from MF and FD were made and assessed using compendial and noncompendial methods. ASD-IBP/MF and ASD-IBP/FD formulations showed a similar drug release profile. In addition, 12 h of sustained IBP release from the ASD-IBP-containing tablets was obtained in a phosphate buffer with a pH of 6.8. From the dissolution kinetics analysis, the Weibull model fitted well. The drug release pattern indicated minimal variations between tablets formed using ASD-IBP prepared by both procedures; however, pre- and postcompression assessment parameters differed. From these findings, the application of ASD and sustained-release polymers in matrix formation might be beneficial in improving the solubility and absorption of poorly soluble drugs such as IBP.

摘要

本研究旨在通过制备无定形固体分散体(ASD)并随后制成缓释片剂,改善难溶性药物布洛芬(IBP)的生物制药、机械和压片性能。通过利用IBP在各种聚合物溶液中的表观溶解度,选择一种合适的聚合物来开发ASD系统。采用熔融法制备了含有不同比例IBP和所选聚合物的ASD。对通过冷冻干燥(FD)法制备的含有优化药物 - 聚合物比例的ASD进行了表征,并进行了物理化学比较。当分别通过熔融法和冷冻干燥法将IBP制成ASD时,其在水中的溶解度分别提高了28倍和35倍。精确的制剂显示IBP呈无定形且表面积增加,从而提高了溶解度。在熔融法和冷冻干燥法中,优化后的ASD - IBP在pH 6.8磷酸盐缓冲液中60分钟后的溶出模式提高了3倍。此外,制备了包含来自熔融法和冷冻干燥法的优化ASD颗粒的直接压片,并使用药典和非药典方法进行评估。ASD - IBP / MF和ASD - IBP / FD制剂显示出相似的药物释放曲线。此外,在pH为6.8的磷酸盐缓冲液中,含ASD - IBP的片剂实现了12小时的IBP持续释放。从溶出动力学分析来看,威布尔模型拟合良好。药物释放模式表明,使用两种方法制备的ASD - IBP制成的片剂之间差异极小;然而,压片前和压片后的评估参数有所不同。基于这些发现,ASD和缓释聚合物在基质形成中的应用可能有利于改善难溶性药物如IBP的溶解度和吸收。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/8327060e5e85/APS2024-2303942.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/f36fd9a87b19/APS2024-2303942.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/c41491fcb5b6/APS2024-2303942.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/c48ab35ea1ba/APS2024-2303942.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/24616d81202a/APS2024-2303942.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/eed22752e9b1/APS2024-2303942.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/ca17088b1e6f/APS2024-2303942.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/8327060e5e85/APS2024-2303942.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/f36fd9a87b19/APS2024-2303942.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/c41491fcb5b6/APS2024-2303942.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/c48ab35ea1ba/APS2024-2303942.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/24616d81202a/APS2024-2303942.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/eed22752e9b1/APS2024-2303942.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/ca17088b1e6f/APS2024-2303942.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/11150040/8327060e5e85/APS2024-2303942.007.jpg

相似文献

1
Impact of Methods of Preparation on Mechanical Properties, Dissolution Behavior, and Tableting Characteristics of Ibuprofen-Loaded Amorphous Solid Dispersions.制剂方法对载布洛芬无定形固体分散体的机械性能、溶出行为及压片特性的影响
Adv Pharmacol Pharm Sci. 2024 May 28;2024:2303942. doi: 10.1155/2024/2303942. eCollection 2024.
2
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
3
Polymer Type Impacts Amorphous Solubility and Drug-Rich Phase Colloidal Stability: A Mechanistic Study Using Nuclear Magnetic Resonance Spectroscopy.聚合物类型对无定形溶解度和富含药物相胶体稳定性的影响:使用核磁共振波谱法进行的机制研究。
Mol Pharm. 2020 Apr 6;17(4):1352-1362. doi: 10.1021/acs.molpharmaceut.0c00061. Epub 2020 Mar 5.
4
Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.药物和聚合物的一致释放:无定形固体分散体溶解中的“最佳点”。
J Control Release. 2019 Mar 28;298:68-82. doi: 10.1016/j.jconrel.2019.01.039. Epub 2019 Feb 4.
5
Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.片剂制剂及后续薄膜包衣对无定形固体分散体过饱和溶解行为的影响。
Int J Pharm. 2018 Apr 5;540(1-2):171-177. doi: 10.1016/j.ijpharm.2018.02.013. Epub 2018 Feb 12.
6
Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.包含高粘度聚合物和介孔硅的三元无定形固体分散体增强了溶解性能。
Mol Pharm. 2021 Jan 4;18(1):198-213. doi: 10.1021/acs.molpharmaceut.0c00811. Epub 2020 Dec 8.
7
Variable-Temperature NMR Analysis of the Thermodynamics of Polymer Partitioning between Aqueous and Drug-Rich Phases and Its Significance for Amorphous Formulations.变温核磁分析聚合物在水相和药物富相之间分配热力学及其对无定形制剂的意义。
Mol Pharm. 2022 Jan 3;19(1):100-114. doi: 10.1021/acs.molpharmaceut.1c00664. Epub 2021 Oct 26.
8
The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.稀释剂对无定形固体分散体片剂的压缩、溶解和物理稳定性的影响。
Int J Pharm. 2024 Apr 10;654:123924. doi: 10.1016/j.ijpharm.2024.123924. Epub 2024 Feb 22.
9
Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.无定形固体分散体中药物和聚合物的一致释放:对药物-聚合物氢键、表面结晶和玻璃化转变作用的深入了解。
Mol Pharm. 2020 Apr 6;17(4):1261-1275. doi: 10.1021/acs.molpharmaceut.9b01272. Epub 2020 Mar 17.
10
Impact of polymer type, ASD loading and polymer-drug ratio on ASD tablet disintegration and drug release.聚合物类型、ASD 载药量和聚合物-药物比对 ASD 片剂崩解和药物释放的影响。
Int J Pharm. 2021 Jan 5;592:120087. doi: 10.1016/j.ijpharm.2020.120087. Epub 2020 Nov 12.

本文引用的文献

1
A concise summary of powder processing methodologies for flow enhancement.用于改善流动性的粉末加工方法的简要概述。
Heliyon. 2023 May 24;9(6):e16498. doi: 10.1016/j.heliyon.2023.e16498. eCollection 2023 Jun.
2
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions.载药聚合物胶束:在生物相关条件下对其进行特征描述和评估的技术分析。
J Control Release. 2021 Apr 10;332:312-336. doi: 10.1016/j.jconrel.2021.02.031. Epub 2021 Feb 27.
3
Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems.
探索沉淀抑制剂以提高辛尼嗪从超饱和脂质给药系统的体内吸收。
Eur J Pharm Sci. 2021 Apr 1;159:105691. doi: 10.1016/j.ejps.2020.105691. Epub 2020 Dec 24.
4
Amphiphilic Small-Molecule Assemblies to Enhance the Solubility and Stability of Hydrophobic Drugs.两亲性小分子组装体用于增强疏水性药物的溶解度和稳定性
ACS Omega. 2020 Oct 20;5(43):28375-28381. doi: 10.1021/acsomega.0c04395. eCollection 2020 Nov 3.
5
Amorphous solid dispersion of ibuprofen: A comparative study on the effect of solution based techniques.布洛芬无定形固体分散体:基于溶液技术的影响比较研究。
Int J Pharm. 2019 Dec 15;572:118816. doi: 10.1016/j.ijpharm.2019.118816. Epub 2019 Oct 31.
6
In vitro comparative quality assessment of different brands of norfloxacin tablets available in Jimma, Southwest Ethiopia.埃塞俄比亚西南部吉马地区市售不同品牌诺氟沙星片的体外质量比较评估
Drug Des Devel Ther. 2019 Apr 17;13:1241-1249. doi: 10.2147/DDDT.S189524. eCollection 2019.
7
Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction.多潘立酮纳米晶体提高口服生物利用度:制备、评价及聚合物-多潘立酮纳米晶体相互作用的分子研究。
Drug Deliv Transl Res. 2019 Feb;9(1):284-297. doi: 10.1007/s13346-018-00596-w.
8
Impact of Method of Preparation of Amorphous Solid Dispersions on Mechanical Properties: Comparison of Coprecipitation and Spray Drying.无定形固体分散体制备方法对力学性能的影响:共沉淀法与喷雾干燥法的比较。
J Pharm Sci. 2019 Feb;108(2):870-879. doi: 10.1016/j.xphs.2018.09.008. Epub 2018 Sep 19.
9
Current Designs of Polymer Blends in Solid Dispersions for Improving Drug Bioavailability.用于提高药物生物利用度的固体分散体中聚合物共混物的当前设计
Curr Drug Metab. 2018;19(13):1111-1118. doi: 10.2174/1389200219666180628171100.
10
Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina.阿根廷布宜诺斯艾利斯市市售的九个品牌美洛昔康片剂溶出度曲线的比较。
Saudi Pharm J. 2018 May;26(4):578-584. doi: 10.1016/j.jsps.2018.01.015. Epub 2018 Feb 9.